News Daily News ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show Michael O'Riordan December 21, 2020
News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Features Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine Shelley Wood December 10, 2020
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Conference News AHA 2020 No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk Michael O'Riordan November 19, 2020
News Daily News Lotus Edge TAVR Device Recalled and Discontinued Worldwide Michael O'Riordan November 18, 2020
News Conference News AHA 2020 INVESTED: No Added CV Benefit From High-Dose Flu Vaccine Todd Neale November 17, 2020
News Conference News AHA 2020 SCAPIS: CTA Finds Silent CAD in 42% of Middle-aged Adults Shelley Wood November 13, 2020
News Conference News AHA 2020 One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3 Michael O'Riordan November 13, 2020
News Conference News AHA 2020 Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol Michael O'Riordan November 12, 2020
News Daily News Coronary Calcium Scans May ID Patients Who Benefit From Aspirin Michael O'Riordan October 30, 2020
News Daily News More Teamwork, Coordination Could Boost CV Studies in COVID-19 Shelley Wood October 28, 2020
News Daily News Thrombotic Events Frequent Among COVID-19 Patients in ICUs Michael O'Riordan October 27, 2020
News Conference News TCT 2020 Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19 Michael O'Riordan October 14, 2020